Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c870
Identifier NCT05910528
Trial Title Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohns Disease
Interventions DRUG: Afimkibart
Participant Information
Sponsor Hoffmann-La Roche
City Dothan
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2023-07-24
Primary Completion Date 2030-12-31
Completion Date 2030-12-31